Yahoo Web Search

Search results

    • Q1 2024 Royalty Pharma PLC Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 2 minutes ago

      Journal of Medicine and highlights the clear potential of frexalimab as a high efficacy, non-lymphocyte depleting therapy for multiple sclerosis. Frexalimab significantly ...